跳至主要内容

Factors Affecting Pharmacokinetics of Drugs


There are four factors that will influence the pharmacokinetic drugs test: water-solubility; fat-soluble; dissociation degree and molecular weight.
Pharmacokinetic is a quantitative study of drugs in the body absorption, distribution, metabolism and excretion of the law.  The use of mathematical principles and methods to explain the plasma concentration with time changes in a discipline.
Water is the carrier of drug transport and the body of the medium. Drugs in the absorption site must have a certain degree of water solubility in a dissolved state, so that can be absorbed. Therefore, the drug is required to have certain water solubility. Polarity (the introduction of polar groups can increase water solubility), crystal form (the impact of drug bioavailability is more and more attention), the melting point of the solubility, thus affecting the absorption of drugs, affecting bioavailability.
Cell membrane of the double lipid layer structure requires a certain lipid-soluble drugs can penetrate the cell membrane. Come in (some fat-soluble), get out (some water-soluble).  Dissolve easily dissociable groups such as carboxyl groups. Through the modification of chemical structure, the introduction of fat-soluble groups or side chains, can improve the drug fat-soluble, promote drug absorption and improve bioavailability.
Factors Affecting Pharmacokinetics of Drugs
Drugs can only pass through biofilm in molecular form. Biofilm itself with a charge, phase suction, into the come, get out; reprimand: not come. Ions with hydration, the drug molecule volume increases, cannot pass through the biofilm microspores. The greater the dissociation is, the worse the absorption.
The degree of dissociation is related to the dissociation constant of the drug and the pH of the absorption site. The dissociation degree of the same drug in different parts is different and the degree of absorption is different. Weak acid drug dissociation in the stomach is small, easy to be absorbed; in the intestine, weak alkaline drug dissociation is small, so it is the weak alkaline drug absorption site.
Strong acid and alkali drugs and ionic drugs are difficult to absorb, as well as difficult to come out after entering the cell.
Excretion is the process of drug excreted from the body. The kidneys are the main organs of drug excretion. Protracted by the kidneys excreted drugs in the renal tubules can be reabsorption, so that the role of drug extension. Re-absorption by the urine pH effect, the application of acidic or alkaline drugs, changes the pH of the urine, can reduce renal tubular reabsorption of drugs.
Medicilon’s pharmacokinetics department offers the clients a broad spectrum of high quality of services in the areas of in vitro ADME. With SPF animal laboratory, Medicilon can provide you, such as mice, rats, rabbits and other different species of animal pharmacokinetics experiments and the route of administration and the way is also a variety of intravenous, gavage, subcutaneous and abdominal wait.
标签：

评论

发表评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou
发表评论
阅读全文

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d
发表评论
阅读全文

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in  Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati
发表评论
阅读全文